● Recruiting

Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context

Condition: Crohn Disease (CD) · Ulcerative Colitis (UC) · Sponsor: Imelda GI Clinical Research Center

PhaseN/A

Planned participants100

Who can joinAll sexes, 16 Years to no upper limit

Healthy volunteersNo

About this study

Prospectively study the correlation between Leucine-rich α2-glycoprotein (LRG) and clinical/endoscopic/histological disease activity in patients with inflammatory bowel disease (IBD) in Europe.

This description comes directly from the study's public registry record.

Talk to the study team

Peter Bossuyt · MD PhD · peter.bossuyt@imelda.be

Always discuss trial participation with your own doctor first.

Locations (1)

Imelda General Hospital

Bonheiden, Belgium

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07621783